| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.04 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.085 | 0.04 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.04 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.05 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.05 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.075 | 0.05 |